Guilford Acquisition Of Gliatech Has Adcon Coverage Growth In Mind
This article was originally published in The Gray Sheet
Executive Summary
The number of private payers willing to reimburse for Gliatech's Adcon line of anti-adhesion gels is expected to increase following the firm's merger with Guilford Pharmaceuticals.